Immunopathology of dermatitis herpetiformis (Q37025707)

17 August 2017

title

Immunopathology of dermatitis herpetiformis (English)

1 reference

17 August 2017

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

30 November 2022

2

T. P. Chorzelski

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1806217

30 November 2022

1

E. H. Beutner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1806217

30 November 2022

author name string

T. L. Reunala

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1806217

30 November 2022

V. Kumar

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1806217

30 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1806217

30 November 2022

publication date

1 July 1991

1 reference

full work available at URL

17 August 2017

https://api.elsevier.com/content/article/PII:0738081X9190021C?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

https://api.elsevier.com/content/article/PII:0738081X9190021C?httpAccept=text/plain

30 November 2022

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

30 November 2022

published in

Clinics in Dermatology

1 reference

17 August 2017

volume

9

1 reference

17 August 2017

issue

3

1 reference

17 August 2017

page(s)

295-311

1 reference

Granular deposits of immunoglobulins in the skin of patients with dermatitis herpetiformis. An immunofluorescent study

17 August 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Small-bowel changes in dermatitis herpetiformis

30 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

The diagnosis of coeliac disease. A commentary on the current practices of members of the European Society for Paediatric Gastroenterology and Nutrition (ESPGAN)

30 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition

30 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Dermatitis herpetiformis: the skin and the gut

30 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Characterization of the mucosal immune response to dietary antigens in patients with dermatitis herpetiformis

30 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Dermatitis herpetiformis: an evaluation of diagnostic criteria

30 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Ultrastructural localization of immunoglobulins in skin of patients with dermatitis herpetiformis

30 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils

30 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Tenascin/hexabrachion in human skin: biochemical identification and localization by light and electron microscopy

30 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

IgA-binding structures in dermatitis herpetiformis skin are independent of elastic-microfibrillar bundles

30 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Antigen-antibody reactions in jejunal mucosa in childhood coeliac disease after gluten challenge.

30 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Immunoglobulins in the jejunal mucosa in adult coeliac disease and dermatitis herpetiformis after the reintroduction of dietary gluten

30 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Gluten challenge in children with dermatitis herpetiformis: a clinical, morphological and immunohistological study

30 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

The pathogenesis of dermatitis herpetiformis: recent advances

30 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

The Pathogenesis of Dermatitis Herpetiformis

30 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

IgA in dermatitis-herpetiformis skin is dimeric

30 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Dermatitis herpetiformis. Cutaneous deposition of polyclonal IgA1

30 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Identification of IgA subclasses in skin of dermatitis herpetiformis patients

30 November 2022

33

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Gluten-free diet in dermatitis herpetiformis. II. Morphological and immunological findings in the skin and small intestine of 12 patients and matched controls

30 November 2022

37

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Long term follow-up of dermatitis herpetiformis with and without dietary gluten withdrawal

30 November 2022

39

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Gluten Challenge in Dermatitis Herpetiformis

30 November 2022

40

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Rapid improvement of dermatitis herpetiformis after elemental diet

30 November 2022

41

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Dermatitis herpetiformis: consequences of elemental diet

30 November 2022

42

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Gluten-free diet and elemental diet in dermatitis herpetiformis

30 November 2022

43

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Circulating immune complexes of IgA type in dermatitis herpetiformis

30 November 2022

44

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

The effect of an elemental diet with and without gluten on disease activity in dermatitis herpetiformis

30 November 2022

45

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Gluten-free diet in dermatitis herpetiformis

30 November 2022

46

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

IgA class antibodies in dermatitis herpetiformis: reaction with tissue antigens

30 November 2022

47

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Recurrent pericarditis and dermatitis herpetiformis. Evidence for immune complex deposition in the pericardium

30 November 2022

48

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Induction of lesions of dermatitis herpetiformis by autologous serum

30 November 2022

49

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

DIAGNOSTIC VALUE OF THE DEMONSTRATION OF GLIADIN ANTIBODIES IN CELIAC DISEASE

30 November 2022

51

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

The adsorption of proteins on erythrocytes treated with tannic acid and subsequent hemagglutination by antiprotein sera

30 November 2022

52

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

A rapid fluorescent solid-phase method for detecting antibodies against milk proteins and gliadin in different immunoglobulin classes

30 November 2022

53

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Immunofluorescent serum gliadin antibodies in children with coeliac disease and various malabsorptive disorders. I. Technique, clinical evaluation and diagnostic use of a gliadin antibody assay using pyruvic aldehyde-treated human red cells

30 November 2022

55

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Immunofluorescent serum gliadin antibodies in children with coeliac disease and various malabsorptive disorders. II. Specificity of Gliadin antibodies: immunoglobulin classes, immunogenic properties of wheat protein fractions, and pathogenic signifi

30 November 2022

56

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Detection of antigliadin antibodies in bullous diseases and their recognition of similar antigenic polypeptides

30 November 2022

57

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

IgA antigliadin antibodies: a marker of mucosal damage in childhood coeliac disease

30 November 2022

58

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Antigliadin antibodies detected by enzyme-linked immunosorbent assay as a marker of childhood celiac disease

30 November 2022

60

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Circulating IgA- and IgG-class antigliadin antibodies in dermatitis herpetiformis detected by enzyme-linked immunosorbent assay

30 November 2022

61

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Antibodies to dietary antigens in coeliac disease

30 November 2022

62

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Evaluation of gliadin antibodies for detection of coeliac disease

30 November 2022

63

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Antigliadin and antireticulin antibodies in children with dermatitis herpetiformis

30 November 2022

64

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Avidity of antigliadin IgA and IgG antibodies in gluten-sensitive enteropathy and dermatitis herpetiformis

30 November 2022

66

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Antibodies to gliadin by ELISA as a screening test for childhood celiac disease

30 November 2022

67

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

What is the role of gliadin in bullous pemphigoid?

30 November 2022

68

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Increased gliadin antibodies in dermatitis herpetiformis and pemphigoid

30 November 2022

69

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Possible role for a human adenovirus in the pathogenesis of celiac disease

30 November 2022

71

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Lack of a serologic response to an E1B protein of adenovirus 12 in coeliac disease

30 November 2022

72

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Evidence for the role of a human intestinal adenovirus in the pathogenesis of coeliac disease

30 November 2022

73

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Thyroid abnormalities in dermatitis herpetiformis. Prevalence of clinical thyroid disease and thyroid autoantibodies

30 November 2022

74

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Prevalence of thyroid abnormalities in patients with dermatitis herpetiformis and in control subjects with HLA-B8/-DR3

30 November 2022

75

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

HL-A8: a genetic link between dermatitis herpetiformis and gluten-sensitive enteropathy

30 November 2022

76

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Tissue antibodies in dermatitis herpetiformis and adult coeliac disease

30 November 2022

78

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Anti-reticulin antibodies in childhood coeliac disease

30 November 2022

79

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Antireticulin antibody: Incidence and diagnostic significance

30 November 2022

80

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Types of 'reticulin' antibodies detected in human sera by immunofluorescence

30 November 2022

81

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

IgA class reticulin antibodies in relatives of patients with coeliac disease

30 November 2022

82

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Circulating reticulin autoantibodies of IgA class in dermatitis herpetiformis

30 November 2022

83

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

IgA class reticulin antibodies in dermatitis herpetiformis: a good indicator of jejunal damage

30 November 2022

84

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Comparison of IgA-class reticulin and endomysium antibodies in coeliac disease and dermatitis herpetiformis

30 November 2022

85

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Sensitivity and specificity of IgA-class antiendomysial antibodies for dermatitis herpetiformis and findings relevant to their pathogenic significance

30 November 2022

87

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

IgA anti-endomysium antibody. A new immunological marker of dermatitis herpetiformis and coeliac disease

30 November 2022

89

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

IgA endomysium antibody in children with dermatitis herpetiformis treated with gluten-free diet

30 November 2022

91

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Aggressive gluten challenge of dermatitis herpetiformis cases converts them from seronegative to seropositive for IgA-class endomysial antibodies

30 November 2022

92

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Disease specificity and dynamics of changes in IgA class anti-endomysial antibodies in celiac disease

30 November 2022

94

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Antiendomysial antibody--useful serological indicator of dermatitis herpetiformis

30 November 2022

95

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Endomysial antibodies in the diagnosis of celiac disease and the effect of gluten on antibody titers

30 November 2022

96

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

IgA anti-endomysial antibody detection in the serum of patients with dermatitis herpetiformis following gluten challenge.

30 November 2022

97

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

IgG endomysial antibodies in IgA-deficient patient with coeliac disease

30 November 2022

99

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

IgA antiendomysial antibodies in dermatitis herpetiformis

30 November 2022

100

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Anti-endomysial antibodies. A serologic marker of dermatitis herpetiformis

30 November 2022

101

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

IgA class antibodies in dermatitis herpetiformis: reaction with tissue antigens

30 November 2022

102

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Are immunological markers of gluten-sensitive enteropathy detectable in IgA nephropathy?

30 November 2022

103

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

IgA anti-endomysial antibodies in dermatitis herpetiformis: correlation with jejunal morphology, gluten-free diet and anti-gliadin antibodies

30 November 2022

104

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

Immunology of celiac disease: tissue and species specificity of endomysial and reticulin antibodies

30 November 2022

107

1 reference

https://api.crossref.org/works/10.1016/0738-081X(91)90021-C

30 November 2022

Identifiers

1 reference

17 August 2017

1 reference